Regencell Bioscience Holdings Ltd RGC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.10
- Day Range
- $5.61–5.61
- 52-Week Range
- $3.31–31.39
- Bid/Ask
- $5.04 / $5.77
- Market Cap
- $73.00 Mil
- Volume/Avg
- 153 / 4,455
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 12
Comparables
Valuation
|
Metric
|
RGC
|
02552
|
06600
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 8.55 |
Price/Book Value | 6.00 | — | 3.07 |
Price/Sales | — | 18.32 | 3.35 |
Price/Cash Flow | — | — | 8.78 |
Price/Earnings
RGC
02552
06600
Financial Strength
|
Metric
|
RGC
|
02552
|
06600
|
|---|---|---|---|
Quick Ratio | 19.15 | 3.53 | 3.64 |
Current Ratio | 19.15 | 3.80 | 3.80 |
Interest Coverage | — | −36.00 | 17.68 |
Quick Ratio
RGC
02552
06600
Profitability
|
Metric
|
RGC
|
02552
|
06600
|
|---|---|---|---|
Return on Assets (Normalized) | −33.37% | −14.39% | 22.25% |
Return on Equity (Normalized) | −35.23% | — | 34.03% |
Return on Invested Capital (Normalized) | −34.27% | −55.97% | 25.10% |
Return on Assets
RGC
02552
06600
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Klgznkjv | Lhntfv | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Nxfskhgnf | Dcmfs | $68.9 Bil | |
HLN
| Haleon PLC ADR | Xgnslhfv | Sxql | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pjkzrzx | Drl | $14.8 Bil | |
VTRS
| Viatris Inc | Hwzxpwrz | Gfz | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mvzhckmr | Gnsr | $11.9 Bil | |
CTLT
| Catalent Inc | Gbnyqsrrf | Czzzt | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ymhkwzp | Wwdj | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Pmjxsbyl | Qxpc | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yhhpdshsr | Xjdvhcm | $3.5 Bil |